Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1092 | 975 | 1092 | 1046 | 1217 | - |
Fund Return | 9.19% | -2.54% | 9.19% | 1.5% | 4.01% | - |
Place in category | 54 | 24 | 54 | 23 | 134 | - |
% in Category | 9 | 4 | 9 | 4 | 30 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.18B | 34.69 | 8.33 | 12.04 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.65B | 28.90 | 6.79 | 9.56 | ||
UBS CH Vitainvest 50 World U | 4.42B | 7.32 | -1.50 | 2.35 | ||
UBS CH Institutional Fund 2 EquiSCA | 3.15B | 16.90 | 0.55 | 6.47 | ||
UBS CH Institutional Fund 2 EquiSCX | 3.15B | 17.20 | 0.81 | 6.76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.67B | 7.50 | -0.45 | 5.93 | ||
UBS CH Equity Fund Swiss Income CHF | 2.42B | 8.29 | 0.69 | 5.71 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.42B | 9.00 | 1.31 | 6.36 | ||
Raiffeisen Futura Swiss Stock A | 2.28B | 5.94 | -3.58 | 5.89 | ||
Pictet CH Institutional Swiss EquiZ | 2.2B | 5.11 | -2.91 | 6.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 9.50 | 77.50 | +0.31% | |
Novartis | CH0012005267 | 9.22 | 97.71 | -0.88% | |
UBS Group | CH0244767585 | 9.04 | 30.16 | +3.64% | |
Roche Holding Participation | CH0012032048 | 9.03 | 287.70 | -1.24% | |
Zurich Insurance Group | CH0011075394 | 8.87 | 562.40 | +0.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review